carcinoma remains controversial. We sought to examine the perioperative risk and survival
outcomes in a large Western series of patients undergoing limited (D0/D1) vs extended
(D1+/D2) lymphadenectomy (LAD) for gastroesophageal carcinoma. Study Design
Clinicopathologic and treatment factors for 520 patients with gastroesophageal carcinoma
undergoing potentially curative resection at a single institution from 1995 to 2017 were …